Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00211731 · ClinicalTrials.gov registry record · NA
Preventing Recurrent Stroke in Minority Populations
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 87
- Enrollment target
NCT00211731 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 87 participants.
The verdict
NCT00211731, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 87 participants
- Enrollment target
Study Summary
This study focuses on causes of under-use of secondary stroke preventive measures demonstrated in randomized clinical trials to be efficacious, but not appropriately utilized in urban, minority populations.
Interventions
- BEHAVIORAL Chronic Disease Self Management Course
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2002-09 |
| Est. Completion | 2007-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00211731
The ClinicalTrials.gov registry entry for NCT00211731 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 87 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Chronic Disease Self Management Course is the first listed.
NCT00211731 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00211731 about?
NCT00211731 is a clinical study titled "Preventing Recurrent Stroke in Minority Populations". This study focuses on causes of under-use of secondary stroke preventive measures demonstrated in randomized clinical trials to be efficacious, but not appropriately utilized in urban, minority populations.
What is the current status of trial NCT00211731?
This trial is currently completed. It is a NA study. The enrollment target is 87 participants. The study started on 2002-09. Estimated completion is 2007-01.
What interventions are being tested in trial NCT00211731?
The interventions under investigation include: Chronic Disease Self Management Course (BEHAVIORAL).
Who is sponsoring clinical trial NCT00211731?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.